Eli Lilly has issued a public health alert about a potentially dangerous impurity found in compounded versions of its weight-loss drug Zepbound. The company warns that the impurity, formed when tirzepatide mixes with vitamin B12, poses unknown risks to co
Scientists are increasingly finding evidence that Boswellia serrata, an herbal extract used for centuries in Ayurvedic medicine, could help reduce inflammation, ease arthritis pain, improve asthma symptoms, and potentially slow cancer growth.
Leading pharmacists and Kidney Care UK warn that common anti-inflammatory drugs like ibuprofen may raise the risk of deadly kidney disease, urging patients to monitor usage and consider alternatives.
As expensive GLP-1 drugs like Ozempic face side effect concerns, allulose, a low-calorie natural sweetener, is gaining attention for aiding weight loss, with one woman reporting a 74-pound drop in 10 months.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Tammy Croston, 47, claims Depo-Provera injections caused four brain tumours and vision loss. She joins thousands suing Pfizer, but Scottish jurisdiction laws block her compensation fight.
A Catholic priest has issued a stark warning that modern financial systems and digital technologies could create conditions for the Antichrist's emergence through economic control, as described in biblical prophecy.
A new study reveals weight-loss jab Wegovy may carry the highest risk of sudden sight loss, known as an eye stroke, compared to similar medications like Ozempic.
A study reveals Wegovy users face nearly five times the risk of sudden sight loss compared to Ozempic users, with 'eye strokes' potentially linked to semaglutide.
The FDA has declined to approve leucovorin, a $2.50 vitamin pill, for autism, despite earlier praise from officials. It was approved for cerebral folate deficiency, a condition linked to autism in many cases.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
The FDA has approved leucovorin for a rare genetic brain condition while explicitly rejecting earlier White House suggestions it could treat autism. Prescriptions surged after Trump's comments.
The FDA has approved leucovorin for a rare genetic condition affecting folate delivery to the brain, but found little evidence to support its use for autism, contradicting earlier White House claims.
Experts warn the pipeline for new antibiotics has shrunk by 35%, with global deaths from drug-resistant infections forecast to hit 8 million annually by 2050. GSK leads research, but AstraZeneca is absent.
Crescent Pharma Limited recalls a batch of Ramipril 5 mg Capsules due to a manufacturing error that may have swapped them with Amlodipine tablets, prompting MHRA warnings about dizziness risks.
Novo Nordisk has dismissed its patent lawsuit against Hims & Hers and entered a collaboration to sell branded weight loss medications through the telehealth platform, sending Hims shares soaring over 40%.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Hims & Hers Health and Novo Nordisk have resolved their patent infringement lawsuit and entered a collaboration to sell branded weight-loss medications through the telehealth platform.
Two deaths in Northern Ireland, suspected to be tied to GLP-1 weight-loss medications like Mounjaro, have been reported to the MHRA. Over 500 adverse reaction reports from 2024-2025 highlight ongoing safety monitoring efforts.
The MHRA received reports of two deaths in Northern Ireland potentially connected to GLP-1 weight-loss medications, amid over 500 adverse reaction reports from 2024-2025.
Crescent Pharma recalls Ramipril 5mg batch GR164099 after a patient found Amlodipine tablets inside. The MHRA urges pharmacies and patients to check packaging immediately.
Eli Lilly's redesigned Mounjaro KwikPens will launch in the UK from April 2026, eliminating leftover medication that enabled a risky 'golden dose' practice amid price hikes.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Clinton James, a father-of-three battling rare medullary thyroid cancer, faces imminent death after losing subsidised access to Retevmo drug that was keeping him alive.
Danish biotech firm Zealand Pharma saw its shares plummet over 30% after mid-stage trial results for obesity drug petrelintide lagged behind rival treatments from Eli Lilly.
New analysis reveals semaglutide, used in Wegovy and Ozempic, could be produced for $3 a month, potentially expanding treatment for obesity and diabetes in 160 countries as patents expire.
The family of Huw Jones, who died from bile duct cancer, is calling on NHS officials to approve zanidatamab, a treatment that offers hope for patients with this aggressive disease.
CVS Health warns it may close all 134 pharmacies in Tennessee if Senate Bill 2040 passes, impacting 1.5 million patients and 2,000 jobs, amid debates over PBM ownership conflicts.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
An experimental drug, zorevunersen, has shown up to 91% reduction in seizures for children with Dravet syndrome in early trials, offering hope for improved quality of life.
Reality star Savannah Chrisley received an FDA warning letter about misleading claims on her GoodGirlRX website regarding compounded GLP-1 weight loss medications.
The FDA's top drug regulator is working to hire a researcher friend who wants new warnings on antidepressants, raising conflict of interest concerns about pregnancy risk claims.
A new study reveals GLP-1 drugs, such as Ozempic and Wegovy, may lower emergency visits and hospitalisations for chronic migraine sufferers by up to 14%.
The Fundraising Regulator has ruled the Universal Church of the Kingdom of God failed to protect vulnerable donors, including a woman who gave her life savings, amid calls for tougher action on high-control religious groups.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Nearly 2,000 doses of dangerous illegal weight-loss medications, valued at over £250,000, were confiscated in Lincolnshire raids targeting a criminal network producing fake jabs.
